News

Hemlibra (emicizumab), the only treatment currently available for haemophilia A via the NHS that doesn't require an ...
From trade associations to medtech innovators and biotech start-ups, here’s a comprehensive look at the latest boardroom ...
"For decades, bureaucrats and entrenched interests buried health data and blocked patients from taking control of their ...
The recent move to introduce an “Amazon-style” prescription tracking in the NHS App is a crucial first step. People want transparency and agency in how care is delivered and patients are more likely ...
In a new study, the large-language model (LLM) ChatGPT was able to reduce the time needed to review whether a patient is suitable for a clinical trial and delivered big reductions – from an average of ...
The target is to reduce its workforce to less than 5,000 from a level of 5,800 at the end of 2024, said chief executive ...
President Donald Trump has given leading pharma manufacturers a 60-day deadline to come up with a most favoured nation (MFN) ...
The C-Suite Innovators' Playbook is brought to you in partnership with EVERSANA.
AI, integrated customer journeys, and breaking down internal silos aren’t just trends – they’re business imperatives. In this ...
In the current climate of capital constraints, tariffs, and policy uncertainty, as well as changing regulatory dynamics, ...
At ASCO 2025, Actuate gave an oral presentation on positive Phase 2 combination data for elraglusib, highlighting its ...
The results of the SURPASS-CVOT trial showed that dual GLP-1/GIP agonist Mounjaro (tirzepatide) was as effective as Lilly's ...